Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Favipiravir (T-705) for severe fever with thrombocytopenia syndrome
ChiCTR1800015894Phase 4Recruiting
- Sponsor
- Beijing Institute of Microbiology and Epidemiology
- Start
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of favipiravir in severe fever with thrombocytopenia syndrome (SFTS) (2 arms), sponsored by Beijing Institute of Microbiology and Epidemiology. Primary endpoints: Case fatality rate of severe fever with thrombocytopenia syndrome and Viral load clearance rate of severe fever with thrombocytopenia syndrome virus. Started Apr 2018; status: recruiting.
02
Drugs
favipiravir
03
Conditions
severe fever with thrombocytopenia syndrome (SFTS)
Beyond the preview
Go deeper on ChiCTR1800015894.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800015894.